IVD in Singapore and Malaysia

  • ID: 2781446
  • Report
  • Region: Malaysia, Singapore
  • 200 Pages
  • Kalorama Information
1 of 5
IVD in Singapore and Malaysia

Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia.

IVD in Singapore and Malaysia contains the following information:
  • Healthcare Statistics for Singapore and Malaysia
  • Significant Hospitals in both countries
  • The Clinical Lab Market in both Singapore and Malaysia
  • Markets for Key Segments: Clinical Chemistry, Microbiology - Molecular, Microbiology - ID/AST, Point of Care - OTC Diabetes, Point of Care - Professional, Point of Care - OTC Other, Immunoassays - Infectious Disease, Immunoassays - Other, Urinalysis, Molecular Diagnostics, Histology, Coagulation, Blood Testing and Typing, Hematology, Flow Cytometry
Multinational competitors participate in the marketplaces of Singapore and Malaysia. Company portraits include the following:
  • Abbott Laboratories (Singapore) Pte Ltd
  • Beckman Coulter Singapore Pte Ltd
  • Becton Dickinson Medical (Singapore) Pte Ltd
  • Bio-Rad Laboratories (Singapore) Pte Ltd
  • bioMérieux Singapore Pte Ltd
  • Life Technologies Holdings Pte Ltd
  • Roche Diagnostics Asia Pacific Pte Ltd
  • Siemens Healthcare Diagnostics Pte Ltd
  • Sysmex Asia Pacific Pte Ltd
Singapore is a leading port and center for the entire Asian-Pacific region, connecting regional trade. Featuring the most developed and highest rated healthcare system in Southeast Asia, Singapore is the headquarters and regional manufacturing center for several medical device, biotechnology, IVD, and pharmaceutical firms. Malaysia, its neighbor, is an upper middle-income country having perhaps the second-most developed healthcare system in the region of Southeast Asia. Through Singapore or Kuala Lumpur, IVD competitors have access to approximately 35 million potential patients, over 700,000 medical tourists yearly, and healthcare systems with higher per capita expenditures than anywhere else in Southeast Asia – or for that matter anywhere in Asia outside of Japan, Australia, or Korea. Singapore and Malaysia represent IVD industries and potential opportunities with solid fundamentals in clinical demand and strong prospects.
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Chapter One: Introduction

- The IVD Markets of Singapore and Malaysia
- Singaporean Healthcare System
-- How Health Care Functions in Singapore – Subsidies, Medisave,
-- MediShield, Medifund and Private Payments
-- Government Funding Programs – Medisave, MediShield and Medifund
-- Subsidized Care
-- Private Payments – Out-of-Pocket, Employer Benefits, Private Insurance
-- Healthcare Infrastructure in Singapore – Hospitals, Clinics, and Private Labs
- Health Status of Singaporeans
-- IVD Product Regulation in Singapore
-- Malaysian Healthcare System
--- How Health Care Functions in Malaysia – Universal Healthcare System and Private Payment
--- Universal Healthcare System
--- Private Payments
--- Healthcare Infrastructure in Malaysia – An Overview of Clinics,
--- Hospitals, and Private Labs
- Health Status of Malaysians
-- IVD Product Regulation in Malaysia

Chapter Two: IVD Market Analysis

- Clinical Chemistry
- Microbiology, ID/AST and Molecular
- Point of Care Testing
- Immunoassays
- Urinalysis
- Molecular Testing
- Coagulation
- Histology
- Hematology
- Blood Testing and Typing
- Flow Cytometry
- Total IVD Markets In Singapore and Malaysia

Chapter Three: IVD Companies And Market Leaders

- Abbott Laboratories (Singapore) Pte Ltd
- Beckman Coulter Singapore Pte Ltd
- Becton Dickinson Medical (Singapore) Pte Ltd
- Bio-Rad Laboratories (Singapore) Pte Ltd
- bioMérieux Singapore Pte Ltd
- Life Technologies Holdings Pte Ltd
- Roche Diagnostics Asia Pacific Pte Ltd
- Siemens Healthcare Diagnostics Pte Ltd
- Sysmex Asia Pacific Pte Ltd
- Affymetrix Singapore Pte Ltd
- ClearBridge BioLoc Pte Ltd
- ClearBridge BioMedics Pte Ltd
- Innogene Kalbiotech Pte Ltd
- MP Biomedicals Asia Pacific Pte Ltd
- PathGEN Dx Pte Ltd
- Sentec Pte Ltd
- Vela Diagnostics
- Volition Pte Ltd

List of Exhibits

Chapter One: Introduction

Figure 1-1: Singaporean and Malaysian IVD Markets
Figure 1-2: Healthcare Spending in Singapore, Malaysia and Comparative Countries – OECD,
Asia-Pacific, Emerging Economies (2011 Total Health Expenditure in Per Capita 2005 PPP Dollars and % of GDP)
Figure 1-3: Singapore Public Hospital Directory
Table 1-3: Singapore Private Hospital Directory
Figure 1-4: Singapore Medical Lab Testing Breakout – Hospitals, Hospital Lab Testing Services, Private Lab / Community Pathology (% of Testing by Value)
Table 1-4: Singaporean Market Private Labs – Company Directory
Figure 1-5: Mortality Rate of Singaporeans and OECD Averages (Deaths per 100,000 population for Coronary Heart Disease, Stroke, Cancer, COPD, Diabetes)
Figure 1-6: Key Adult Singaporean Health Metrics (Hypertension, Diabetes, High Cholestrol, Obesity, Smoker, Asthma, Perceived Health)
Table 1-5: Selected Infectious Disease Incidence Rates (per 100,000 population)
– Singapore, Australia, United States, EU/EEA (Viral Hepatitis, Salmonellosis, Typhoid Fever,
Dengue, Malaria, Bacterial Meningitis, Tuberculosis)
Figure 1-7: Total Population of Malaysia, 2008-2020 (millions)
Figure 1-8: Healthcare Expenditure by Payer and Program In Malaysia (%)
Table 1-6: Malaysian Clinic Survey of Laboratory Capabilities – Dedicated Clinic Lab Space, In- House
Lab Services, Out-Sourced Lab Services (% of Private and Public Primary Care Clinics)
Table 1-7: Malaysian Clinic Survey of Medical Devices/IVD Instruments – Hemoglobin (HbA1c) Analyzer, Chemistry Analyzer, Hematology Analyzer, Bilirubinometer, Ultrasound,
X-Ray (% of Clinics w/ Installed, Private/Public)
Table 1-8: High-Technology or IVD Client Indicators for Malaysian Hospitals – CT Scan, MRI, PET Procedure Volumes; Hospitals Providing General Surgical Services and with ICUs (Private / Public Hospitals)
Table 1-9: Malaysian Market Private Labs – Company Directory
Figure 1-9: Mortality Rate of Malaysians and OECD Averages (Deaths per 100,000 population for Communicable Disease and Infection, Coronary Heart Disease, Stroke, Cancer, Chronic Respiratory Disease, Diabetes)
Figure 1-10: Key Malaysian Health Metrics (Hypertension, Diabetes, High Cholestrol, Obesity, Smoker)
Table 1-10: Selected Infectious Disease Incidence Rates (per 100,000 population) – Malaysia, Singapore, United States, EU/EEA (Viral Hepatitis, Salmonellosis, Typhoid Fever, Dengue, Malaria, Bacterial Meningitis, Tuberculosis)

Chapter Two: IVD Market Analysis

Figure 2-1: Singapore and Malaysia Clinical Chemistry Markets
Figure 2-2: Singapore and Malaysia Microbiology Markets (ID/AST, Molecular)
Figure 2-3: Singapore and Malaysia Point of Care Testing (POCT) Markets (Professional, OTC Diabetes, OTC Other)
Figure 2-4: Singapore and Malaysia Immunoassay Markets (Infectious Disease, Other)
Figure 2-5: Singapore and Malaysia Urinalysis Markets
Figure 2-6: Singapore and Malaysia Molecular Diagnostics Markets
Figure 2-7: Singapore and Malaysia Coagulation Markets
Figure 2-8: Singapore and Malaysia Histology/Cytology Markets
Figure 2-9: Singapore and Malaysia Hematology Markets
Figure 2-10: Singapore and Malaysia Blood Testing and Typing Market
Figure 2-11: Singapore and Malaysia Flow Cytometry Markets
Table 2-1: IVD Market in Singapore by Segment (Clinical Chemistry, Microbiology - ID/AST, Microbiology - Molecular, PointofCare - OTC Diabetes, PointofCare - OTC Other, PointofCare- Professional, Immunoassays - Infectious Disease, Immunoassays - Other, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry)
Table 2-2: IVD Market in Malaysia by Segment (Clinical Chemistry, Microbiology - ID/AST, Microbiology - Molecular, PointofCare - OTC Diabetes, PointofCare - OTC Other, PointofCare- Professional, Immunoassays - Infectious Disease, Immunoassays - Other, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry)
Table 2-3: Combined Singapore-Malaysia IVD Market by Segment (Clinical Chemistry, Microbiology - ID/AST, Microbiology - Molecular, PointofCare - OTC Diabetes, PointofCare - OTC Other, PointofCare- Professional, Immunoassays - Infectious Disease, Immunoassays - Other, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry)

Chapter Three: Singapore And Malaysia - Ivd Companies And Market Leaders

Table 3-1: Singapore and Malaysia IVD Market Leaders
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbott Laboratories (Singapore) Pte Ltd
- Beckman Coulter Singapore Pte Ltd
- Becton Dickinson Medical (Singapore) Pte Ltd
- Bio-Rad Laboratories (Singapore) Pte Ltd
- bioMérieux Singapore Pte Ltd
- Life Technologies Holdings Pte Ltd
- Roche Diagnostics Asia Pacific Pte Ltd
- Siemens Healthcare Diagnostics Pte Ltd
- Sysmex Asi
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll